Wilmington-based contract research giant PPD is joining hands with another clinical development firm to expand the business reach of both.
PPD's agreement with Albuquerque- based Lovelace Biomedical and Environmental Research Institute (LBERI) covers future service opportunities for biopharmaceutical and government clients across a range of therapeutic areas.
The companies said they plan to refer potential business opportunities to one another for laboratory, preclinical and clinical development services they do not offer to their respective clients. In addition, they intend to work together on some new research projects.
"As demand for preclinical services grows, our collaboration with LBERI builds on our strong capabilities and competitive position, particularly in the areas of respiratory, infectious diseases, health outcomes and epidemiology," said David Grange, chief executive officer of PPD.